Y-2 sublingual tablets

Y-2 sublingual tablets · Peking University Third Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Y-2 sublingual tablets, covering 2023-08-22 to 2023-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke [Phase 3]